Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer

Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer

BAAR, Switzerland--(BUSINESS WIRE)--Aug 20, 2025-

Breakthrough Pancreatic Cancer Treatment: Novocure's TTFields Therapy Seeks FDA Approval After Success

Novocure submits PMA application for TTFields therapy in locally advanced pancreatic cancer, following successful PANOVA-3 trial. FDA decision expected H2 2026.